Abiopharma

🔍 Murphy Robert C. (Executive)

Company: Snap Inc (SNAP)

Report Date: 2026-08-05

Detailed Transactions and Holdings:

• Sold 2,533,231 shares of Class A Common Stock (Direct)
  Date: 2026-06-25 | Code: J | equity_swap_involved: false | shares_owned_after: 1,317,819.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 2,533,231 shares of Class A Common Stock (Direct)
  Date: 2026-06-25 | Code: J | equity_swap_involved: false | shares_owned_after: 46,343,022.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 333,438 shares of Class A Common Stock (Direct)
  Date: 2026-06-25 | Code: J | equity_swap_involved: false | shares_owned_after: 815,512.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 333,438 shares of Class A Common Stock (Direct)
  Date: 2026-06-25 | Code: J | equity_swap_involved: false | shares_owned_after: 46,676,460.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 2,866,669 shares of Class A Common Stock (Direct)
  Date: 2026-06-25 | Code: J | equity_swap_involved: false | shares_owned_after: 43,809,791.00 | transaction_form_type: 4 | Footnotes: F3
• Acquired 2,866,669 shares of Class A Common Stock (Direct)
  Date: 2026-06-25 | Code: J | equity_swap_involved: false | shares_owned_after: 2,866,669.00 | transaction_form_type: 4 | Footnotes: F4
• Sold 2,000,000 shares of Class A Common Stock at $5.555 per share (Direct)
  Date: 2026-08-05 | Code: S | equity_swap_involved: false | shares_owned_after: 41,809,791.00 | transaction_form_type: 4 | Footnotes: F5, F6
• Sold 2,000,000 shares of Class A Common Stock at $5.2512 per share (Direct)
  Date: 2026-08-06 | Code: S | equity_swap_involved: false | shares_owned_after: 39,809,791.00 | transaction_form_type: 4 | Footnotes: F5, F7
• Sold 1,223,340 shares of Class A Common Stock (Direct)
  Date: 2026-08-06 | Code: G | equity_swap_involved: false | shares_owned_after: 38,586,451.00 | transaction_form_type: 4 | Footnotes: F8
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-08-05 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 4,963,581.00 | Footnotes: F9

Footnotes:

• F1: Shares held by an entity or entities in which the reporting person retains investment power over such shares. Reflects the distribution of shares transferred from an entity or entities in which the reporting person retains investment power over such shares to the reporting person as an annuity payment on June 25, 2026.
• F2: Reflects the distribution of shares transferred from an entity or entities in which the reporting person retains investment power over such shares to the reporting person as an annuity payment on June 25, 2026.
• F3: Reflects the transfer of shares by the reporting person to an entity in which the reporting person retains investment power over such shares, as the initial funding of a grantor retained annuity trust, on June 25, 2026.
• F4: Shares held by an entity or entities in which the reporting person retains investment power over such shares. Reflects the transfer of shares by the reporting person to an entity in which the reporting person retains investment power over such shares, as the initial funding of a grantor retained annuity trust, on June 25, 2026.
• F5: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2025, as amendeded on February 11, 2026.
• F6: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.495 to $5.70 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F7: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.19 to $5.21 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F8: Represents a charitable gift by the reporting person.
• F9: Shares held by an irrevocable trust over which the reporting person acts as trustee and has voting power, but has no financial interest. The beneficiaries of the irrevocable trust are not immediate family members of the reporting person.